TREN-MIX 250

Name: TREN-MIX 250

Form: Oil Injection

Dosage: 250mg/ml

Package: 10ml/vial; 1vial/box

Inventory: 10000 vials for sell

MOQ: 10 vials

Pack material: Shockproof film, shockproof envelope, and Cartons

Logo: with or without, both ok

OEM: Offer OEM service. Customed dosage & brand & LOGO & package. OEM MOQ 100 vials

Shipment: By express to buyers’ door. 100% make sure delivery

Payment: TT/ Western Union/BTC/ETV/VISA and so on, please contact by email

Shipment time: Within three working days after payment. Usually need ten days to arrive buyers’ address. Resend if lost

Description

TREN-MIX 250

Trenabolone acetate, Trenbolone hexahydrobenzylcarbonate, Trenbolone enanthate

TREN-MIX 250 is a combination of three esters of Trenbolone : Trenabolone Acetate, Trenbolone Hexahydrobenzylcarbonate and Trenbolone Enanthate.

The presence of the acetate ester allows TREN-MIX-250 to display a rapid initial physiological response. The other two esters, which release at slower rates, prolong the physiological response with a relatively flat absorption curve over the duration of the injection life-cycle. TREN-MIX 250 has a great effect on promoting protein synthesis, as well as creating a positive nitrogen balance. It is an appetite stimulant and improves the conversion of proteins. In laboratory tests, it has been demonstrated that Trenbolone acetate increases protein and decreases fat deposition. It has proven to be an excellent product for promoting size and strength in the presence of adequate protein and calories, promotes body tissue building processes, and can reverse catabolism.

Presentation: Each 10ml multidose vial contains 200mg per ml.

he Tren Mix 250 by ATLAS is a Mix of 3 esters of Trenbolone. Trenbolone Acetate 75mg/ml, Trenbolone Enanthate 125mg/ml and Trenbolone Hexahydrobenzylcarbonate 50mg/ml. With this mix you’ll get incredible muscle definition.

Laboratory : Atlas-Pharma,

Form : Injection,

Molecule : Trenbolone mix,

Concentration : 250mg/ml,

Presentation : Vial 10ml,

Recommended dosage : 200-600mg/week

If OVERDOSE is suspected

If you think there has been an overdose, call your poison control center or get medical care right away. Be ready to tell or show what was taken, how much, and when it happened.

Consumer information use

• If your symptoms or health problems do not get better or if they become worse, call your doctor.

• Do not share your drugs with others and do not take anyone else's drugs.

• Keep all drugs in a safe place. Keep all drugs out of the reach of children and pets.

• Throw away unused or expired drugs. Do not flush down a toilet or pour down a drain unless you are told to do so. Check with your pharmacist if you have questions about the best way to throw out drugs. There may be drug take-back programs in your area.

• Some drugs may have another patient information leaflet. Check with your pharmacist. If you have any questions about nandrolone, please talk with your doctor, nurse, pharmacist, or other health care provider.

• If you think there has been an overdose, call your poison control center or get medical care right away. Be ready to tell or show what was taken, how much, and when it happened

Warnings

PELIOSIS HEPATIS, A CONDITION IN WHICH LIVER AND SOMETIMES SPLENIC TISSUE IS REPLACED WITH BLOOD-FILLED CYSTS, HAS BEEN REPORTED IN PATIENTS RECEIVING ANDROGENIC ANABOLIC STEROID THERAPY. THESE CYSTS ARE SOMETIMES PRESENT WITH MINIMAL HEPATIC DYSFUNCTION, BUT AT OTHER TIMES THEY HAVE BEEN ASSOCIATED WITH LIVER FAILURE. THEY ARE OFTEN NOT RECOGNIZED UNTIL LIFE-THREATENING LIVER FAILURE OR INTRA-ABDOMINAL HEMORRHAGE DEVELOPS. WITHDRAWAL OF DRUG USUALLY RESULTS IN COMPLETE DISAPPEARANCE OF LESIONS. LIVER CELL TUMORS ARE ALSO REPORTED. MOST OFTEN THESE TUMORS ARE BENIGN AND ANDROGEN-DEPENDENT, BUT FATAL MALIGNANT TUMORS HAVE BEEN REPORTED. WITHDRAWAL OF DRUG OFTEN RESULTS IN REGRESSION OR CESSATION OF PROGRESSION OF THE TUMOR. HOWEVER, HEPATIC TUMORS ASSOCIATED WITH ANDROGENS OR ANABOLIC STEROIDS ARE MUCH MORE VASCULAR THAN OTHER HEPATIC TUMORS AND MAY BE SILENT UNTIL LIFE-THREATENING INTRA-ABDOMINAL HEMORRHAGE DEVELOPS. BLOOD LIPID CHANGES THAT ARE KNOWN TO BE ASSOCIATED WITH INCREASED RISK OF ATHEROSCLEROSIS ARE SEEN IN PATIENTS TREATED WITH ANDROGENS AND ANABOLIC STEROIDS. THESE CHANGES INCLUDE DECREASED HIGH-DENSITY LIPOPROTEIN AND SOMETIMES INCREASED LOW-DENSITY LIPOPROTEIN. THE CHANGES MAY BE VERY MARKED AND COULD HAVE A SERIOUS IMPACT ON THE RISK OF ATHEROSCLEROSIS AND CORONARY ARTERY DISEASE.

How do I store and/or throw out?

If you need to store it at home, talk with your doctor, nurse, or pharmacist about how to store it.

PROTECT FROM LIGHT. Store in carton until contents are used.

ATTENTION: All these products are strictly for LABORATORY AND RESEARCH PURPOSES ONLY. They are not to be used for any human and veterinary purposes.